Apogee Therapeutics Inc.’s recently made public that its Chief Financial Officer Henderson Jane unloaded Company’s shares for reported $0.29 million on Aug 23 ’24. In the deal valued at $48.26 per share,6,000 shares were sold. As a result of this transaction, Henderson Jane now holds 200,871 shares worth roughly $9.72 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, JANE V HENDERSON bought 6,000 shares, generating $289,570 in total proceeds.
Before that, Dambkowski Carl sold 7,335 shares. Apogee Therapeutics Inc. shares valued at $298,336 were divested by the Chief Medical Officer at a price of $40.67 per share. As a result of the transaction, Dambkowski Carl now holds 287,458 shares, worth roughly $13.91 million.
BofA Securities initiated its Apogee Therapeutics Inc. [APGE] rating to a Buy in a research note published on May 10, 2024; the price target was $80. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. Wedbush began covering APGE with “an Outperform” recommendation on August 08, 2023. TD Cowen started covering the stock on August 08, 2023. It rated APGE as “an Outperform”.
Price Performance Review of APGE
On Tuesday, Apogee Therapeutics Inc. [NASDAQ:APGE] saw its stock fall -5.41% to $48.40. Over the last five days, the stock has gained 2.09%. Apogee Therapeutics Inc. shares have risen nearly 73.23% since the year began. Nevertheless, the stocks have risen 110.99% over the past one year. While a 52-week high of $72.29 was reached on 03/13/24, a 52-week low of $14.19 was recorded on 01/08/24. SMA at 50 days reached $45.06, while 200 days put it at $42.27.
Levels Of Support And Resistance For APGE Stock
The 24-hour chart illustrates a support level at 46.97, which if violated will result in even more drops to 45.54. On the upside, there is a resistance level at 50.75. A further resistance level may holdings at 53.10. The Relative Strength Index (RSI) on the 14-day chart is 54.48, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.76, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 40.32%. Stochastics %K at 82.96% indicates the stock is a selling.
How much short interest is there in Apogee Therapeutics Inc.?
A steep rise in short interest was recorded in Apogee Therapeutics Inc. stocks on 2024-08-15, dropping by -0.43 million shares to a total of 8.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 8.61 million shares. There was a decline of -5.21%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 08, 2023 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $34 price target.
